A Brief Case Study on Disease Area Scenario Planning
A large-cap global pharmaceutical company with an immunology portfolio used Captario SUM® to understand what assets to prioritize within...
top of page
Captario
- May 4, 2022
- 2 min
A Brief Case Study on Portfolio Scenario Planning
A large-cap global pharma company with a robust, diversified portfolio used Captario SUM® to model portfolio launch behavior over time...
Monika Tahiraj
- May 2, 2022
- 4 min
Captario – The Role of HR in a Remote Company
Since its founding in 2012, Captario has never been the traditional company where ”you go to the office.” While there is a physical...
Magnus Ytterstad
- Apr 13, 2022
- 1 min
Does This Chart Add Value?
One method of illustrating risk is to show the value at risk (VaR). Plotting the fifth percentile from the simulated outputs in the left...
Captario
- Apr 5, 2022
- 1 min
3 Quick Questions About Portfolios with Captario Co-Founder Mikael Palmblad
What challenges do pharmaceutical companies make regarding portfolio decisions? The portfolio elements are high-risk, expensive, take a...
Magnus Ytterstad
- Mar 24, 2022
- 1 min
Which Charts and Metrics do You Prefer to Display Value and Risk?
At Captario, we continuously explore risk and return metrics for R&D portfolio assets, and we strive to stay on top of the many excellent...
Magnus Ytterstad
- Feb 10, 2022
- 2 min
How Do You Capture Operational Risk in Your Forecasts?
Drug development is a risky business. Development products carry technical and regulatory risks (PTRS), operational risks (delays and...
Mikael Palmblad
- Jan 27, 2022
- 3 min
The Perks of Using Monte Carlo Simulations in Drug Development
Overall, everything in an organization, and especially a profit driven organization, is possible to quantify. If you have a tough...
Johanna Wendt
- Jan 12, 2022
- 6 min
An Old Lady To the Rescue - A Short Story of User Experience
This is a short story of when I was away from home in a city I had never been to before. I had been away all day, and all that was left...
Captario
- Dec 15, 2021
- 3 min
Improving Pharma Development Forecasting From Scattered Data
Understanding what decisions to make about the future is no easy task. In an earlier article, we outlined the 6 best practices in pharma...
Guest Writer: David Roberts
- Dec 8, 2021
- 4 min
Artificial Intelligence & Machine Intelligence – A Non-Scientist Point of View
Artificial Intelligence, or AI as most everyone calls it, is an exciting term with very little agreement on what it actually means....
Mikael Palmblad
- Nov 24, 2021
- 5 min
The Value of Holistic Modeling
To many people, holistic modeling may seem a novel practice. Actually, holistic modeling is rather old, seen in 1772 in a letter by...
Captario
- Nov 16, 2021
- 5 min
Clinical Effect – A Key Aspect in Drug Development
Understanding the forecasting process and making decisions based on those predictions is not done easily. Without time-machines or real...
Guest Writer: Carlos Nunes
- Nov 15, 2021
- 7 min
Maturing Decision Quality for Pharma R&D
“A great practice in portfolio decision quality strategically manages uncertainty and offers decision makers more reliable foundations to...
Magnus Ytterstad
- Nov 10, 2021
- 2 min
What Are Your Modeling Experiences With QALY?
Recently, Captario had the opportunity to present to a non-profit organization that uses medicine development as one of its...
Shaineze Afir
- Nov 3, 2021
- 9 min
Optimizing Asset Value: A Study of Launch Strategies in the EU
Case Study Background Launching a new molecular entity (NME) has always been an uncertain endeavor for the pharmaceutical industry. To...
Johannes Vänngård
- Oct 20, 2021
- 6 min
Trends in Portfolio Management
Industries are continuously evolving, and the pharma industry is no exception. There are trends impacting the way we think about pharma,...
Mikael Palmblad
- Oct 13, 2021
- 7 min
The Value of Uncertainty
Is there any value in uncertainty? Do you know uncertainty? Is uncertainty a friend, or a foe? Let's start by asking another question:...
Magnus Ytterstad
- Aug 2, 2021
- 1 min
A Quick Case Study on Product Strategy Support
A drug development team saw three paths to get to a successful launch: 1. Best Case: Test the response rate in a small cohort of 20...
Magnus Ytterstad
- Jul 24, 2021
- 5 min
NDA Submission Strategy
A while ago I was engaged in a client project where we developed the launch strategy for a compound targeted for multiple indications....
bottom of page